Playback speed
10 seconds
SABCS 2023 Insights: "PROs From the CAPItello-291 Trial Investigating Capivasertib and Fulvestrant for Patients With Aromatase Inhibitor-Resistant HR+/HER2- Advanced BC"
By
Insights from 2023 SABCS
FEATURING
Hope Rugo
By
Insights from 2023 SABCS
FEATURING
Hope Rugo
572 views
December 15, 2023
Login to view comments.
Click here to Login